Northwestern Medicine scientists have discovered that a specific long non-coding RNA activates oncogenic signaling pathways in prostate cancer cells and drives tumor progression, underscoring its ...

Drugs that block enzymes called tyrosine kinases are among the most effective targeted therapies for cancer. However, they typically work for only 40% to 80% of the patients who would be expected to ...

A new single-cell technology is giving scientists their clearest view yet of immune cell behavior—capturing not just genetic ...

The CXCR6/CXCL16 signalling axis represents a pivotal mediator in the intricate interplay between immune responses, tumour progression and vascular pathology. CXCL16 exists both as a membrane-bound ...

The post HYD Pioneers New Research Revealing Systemic Role of Deuterium-Depleted Water in Cancer Therapy appeared first on Credible PR.

Cancer stem cells (CSCs), a critical subpopulation within tumors, drive cancer initiation, progression, metastasis, relapse, and resistance to therapy ...

Researchers have uncovered an early survival response in ovarian cancer cells that may limit the effectiveness of widely used PARP inhibitors.

Aspirin reduces the risk for colorectal cancer in high-risk groups, such as Lynch syndrome, but shows no benefit in the ...

A recent study published in the International Journal of Molecular Sciences explores how deuterium concentration, an ...